Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth

Journal of Clinical Investigation

Volumn 99, Issue 12, 1997, Pages 2992-2999

  Bry, Kristina ^a,b   Lappalainen, Urpo ^a,b   Hallman, Mikko ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Cytokine; Inflammation; Prematurity; Pulmonary surfactant; Respiratory distress syndrome

Indexed keywords

CYTOKINE; LUNG SURFACTANT; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1ALPHA;

AMNION FLUID; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FETUS; FETUS WEIGHT; LUNG COMPLIANCE; LUNG WEIGHT; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RABBIT; RESPIRATORY DISTRESS SYNDROME;

EID: 0030913005     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119494     Document Type: Article

References (56)

1. Hawgood, S., B.J. Benson, J. Schilling, D. Damm, J.A. Clements, and R.T. White. 1987. Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption. Proc. Natl. Acad. Sci. USA. 84:66-70.
2. Revak, S., T.A. Merritt, E. Degryse, L. Stefani, M. Courtney, M. Hallman, and G.C. Cochrane. 1988. Use of human surfactant low molecular weight (LMW) apoproteins in the reconstitution of surfactant biological activity. J. Clin. Invest. 81:826-833.
3. King, R.J., and M.C. MacBeth. 1979. Physicochemical properties of dipalmitoyl phosphatidylcholine after interaction with an apolipoprotein of pulmonary surfactant. Biochim. Biophys. Acta. 557:86-101.
4. Haagsman, H.P. 1994. Surfactant proteins A and D. Biochiem. Soc. Trans. 22:100-106.
5. Dinarello, C.A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood. 77:1627-1652.
6. Dinarello, C.A. 1992. Role of interleukin-1 in infectious diseases. Immunol Rev. 127:119-146.
7. Van der Meer, J.W.M., M. Barza, S.M. Wolff, and C.A. Dinarello. 1988. A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection. Proc. Natl. Acad. Sci. USA. 85:1620-1623.
8. Wallach, D., H. Holtmann, H.M. Engelmann, and Y. Nophar. 1988. Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. J. Immunol. 140:2994-2999.
9. Denis, M., and E. Ghadirian. 1994. Interleukin-1 is involved in mouse resistance to Mycobacterium avium. Infect. Immun. 62:457-461.
10. Kauma, S., D. Matt, S. Strom, D. Eierman, and T. Turner. 1990. InterIcukin-1β, human leukocyte antigen HLA-DR α, and transforming growth faclor-β expression in endometrium, placenta, and placental membranes. Am. J. Obstet. Gynecol. 163:1430-1437.
11. Menon, R., K.F. Swan, T.W. Lyden, N.S. Role, and S.J. Fortunato. 1995. Expression of inflammatory cytokines (interleukin-1βand interleukin-6) in amniochorionic membranes. Am. J. Obstet. Gynecol. 172:493-500.
12. Arend, W.P. 1991. Interleukin-1 receptor antagonist. A new member of the interleukin 1 family. J. Clin. Invest. 88:1445-1451.
13. Fisher, C.J., Jr., J.F. Dhainaut , S.M. Opal, J.P. Pribble, R.A. Balk, G.J. Slotman, T.J. Iberti, E.C. Rackow, M.J. Shapiro, R.L. Greenman, et al. 1994. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebocontrolled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA (J. Am. Med. Assoc.). 271:1836-1843.
14. Havell, E.A., L.L. Moldawer, D. Helfgott, P.L. Kilian, and P.B. Sehgai. 1992. Type I IL-1 receptor blockade exacerbates murine listeriosis. J. Immunol. 148:1486-1492.
15. Mancilla, J., J.P. Garcia, and C.A. Dinarello. 1993. IL-1 receptor antagonist can either protect or enhance the lethality of Klebsiella pneumonias sepsis in newborn rats. Infect. Immun. 61:926-932.
16. Galve-de-Rochemonteix, B., L.P. Nicod, R. Chicheportiche, S. Lacraz, C. Baumberger, and J.M. Dayer. 1993. Regulation of interleukin-1ra, interleukin-1α. and interleukin-1β production by human alveolar macrophages with phorbol myristate acetate, lipopolysaccharide, and interleukin-4. Am. J. Respir. Cell Mol. Biol. 8:160-168.
17. Bry, K., U. Lappalainen, M. Hallman, and S.P. Eisenberg. 1995. Hydrocortisone stimulates interleukin-1 receptor antagonist production and mRNA expression in amnion cells. Pediatr. Res. 37:59a. (Abstr.)
18. Bry, K., U. Lappalainen, F. Waffarn, K. Teramo, and M. Hallman. 1994. Influence of fetal gender on the concentration of interleukin-1 receptor antagonist in amniotic fluid and in newborn urine. Pediatr. Res. 35:130-134.
19. Romero, R., M. Mazor, F. Brandt, W. Sepulveda, C. Avila, D.B. Cotton, and C.A. Dinarello. 1992. Interleukin-1α and interleukin-1β in preterm and term human parturition. Am. J. Reprod. Immunol. 27:117-123.
20. Watterberg, K.L., L.M. Demers, S.M. Scott, and S. Murphy. 1996. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 97:210-215.
21. Nizet, V., R.L. Gibson, E.Y. Chi, P.E. Framson, M. Hulse, and C.E. Rubens. 1996. Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect. Immun. 64:3818-3826.
22. Smith, P.K., R.I. Krohn, G.T. Hermanson, A.K. Malia, F.H. Gartner, M.D. Provenzano, E.K. Fujitnoto, N.M. Goeke, B.J. Olson, and D.C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biocliem. 150:76-85.
23. Shapiro, O.L., and B K. Schrier. 1973. Cell cultures of fetal rat brain. Growth and marker enzyme development. Exp. Cell Res. 77:239-247.
24. Rider, E.D., M. Ikegami, J.A. Whittsett, W. Hull, M. Absolom, and A.H. Jobc. 1993. Treatment responses to surfactants containing natural surfactant proteins in preterm rabbits. Am. Rev. Respir. Dis. 147:669-676.
25. Robertson, B., and B. Lachmann. 1988. Experimental evaluation of surfactants for replacement therapy. Exp. Lung Res. 14:279-310.
26. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:556-159.
27. Hallman, M., T.A. Merritt, T. Akino, and K. Bry. 1991. Surfactant protein A, phosphatidylcholine and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of RDS and outcome of small premature infants. Am. Rev. Respir. Dis. 144:1376-1384.
28. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature (Lond.). 227:680-685.
29. Krämer, H.J., R. Schmidt, A. Günther, G. Becker, Y. Suzuki, and W. Seeger. 1995. ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid. Am. J. Respir. Crit. Care Med. 152:1540-1544.
30. Beers, M.F., S.R. Bates, and A.B. Fisher. 1992. Differential extraction for the rapid purification of bovine surfactant protein B. Am. J. Physiol. 262: L773-L778.
31. Bligh, E.G., and W.J. Dyer. 1957. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
32. Mason, R.J., J. Nellenbogen, and J.A. Clements. 1976. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J. Lipid Res. 17:281-284.
33. Snyder, J.M., C.R. Mendelson, and J.M. Johnston. 1981. The effect of cortisol on rabbit fetal lung maturation in vitro. Dev. Biol. 85:129-140.
34. Dhar, V., M. Hallman, U. Lappalainen, and K. Bry. 1997. Interleukin 1α upregulates the expression of surfactant protein-A in rabbit lung explants. Biol. Neonate. 71:46-52.
35. Romero, R., M. Mazor, W. Sepulveda, C. Avila, D. Copeland, and J. Williams. 1992. Tumor necrosis factor in term and preterm labor. Am, J. Obstet. Gynecol. 166:1576-1587.
36. Bry, K., and M. Hallman. 1993. Transforming growth factor-β prevents preterm delivery induced by interleukin-1α and tumor necrosis factor-α in the rabbit. Am. J. Obstet. Gynecol. 168:1318-1322.
37. Post, M., and B.T. Smith. 1992. Hormonal control of surfactant metabolism. In Pulmonary Surfactant: from Molecular Biology to Clinical Practice. B. Robertson, L.M.G. Van Golde, and J.J. Batenburg, editors. Elsevier Science, Amsterdam. The Netherlands. 379-424.
38. Odom, M.J., J.M. Snyder, Y. Boggaram, and C.R. Mendelson. 1988. Glucocorticoid regulation of the major surfactant-associated protein (SP-A) and its rnRNA and of morphologic development of human fetal lung in vitro. Endocrinology. 123:1712-1720.
39. Schellhase, D.E., and J.M. Shannon. 1991. Effects of maternal dexamethasone expression of SP-A, SP-B and SP-C in the fetal rat lung. Am. J. Respir. Cell Mol. Biol. 4:304-312.
40. Gross, I., D.W. Dynia, S.A. Rooney, D.A. Smart, J.B. Warshaw, J.F. Sissom, and S.B. Hoath. 1986, Influence of epidermal growth factor on fetal lung development in vitro. Pediatr. Res. 20:473-477.
41. Haigh, R.M., M. Hollingsworth, L.A. Micklewright, R.D.H. Boyd, and S.W. D'Souza. 1988. The effect of human urogastronc on lung phospholipids in fetal rabbits. J. Dev. Physiol 10:433-443.
42. r = 35,000 surfactant-associated protein in fetal lung. J. Biol. Chem. 262:7908-7913.
43. Goetzman, B.W., L.C. Read, CG. Plopper, A.F. Tarantal, C. GeorgeNascimento, T.A. Merritt, J.A. Whitsett, and D. Styne. 1994. Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants. Pediatr. Res. 35:30-36.
44. Ballard, P.L., H.G. Liley, L.W. Gonzales, M.W. Odom, A.J. Ammann, B. Benson, R.T. White, and M.C. Williams. 1990. Interferon-γ and synthesis of surfactant components by cultured human lung. Am. J. Respir. Cell Moi. Biol. 2: 137-143.
45. Wispe, J.R., J.C. Clark, B.B. Warner, D. Fajardo, W.E. Hull, R.B. Holtzman, and J.A. Whitsett. 1990. Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J. Clin. Invest. 86:1954-1960,
46. Dulkerian, S.J., and P.L. Ballard. 1994. Effects of inflammatory mediators on surfactant proteins A and B. Pediatr. Res. 35:296a. (Abstr.)
47. Arias-Diaz, J., E. Vara, C. Garcia, and J.L. Balibrea. 1994. Tumor necrosis factor-α-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandins. J. Clin. Invest. 94: 244-250.
48. Whitsett, J.A., A. Budden, W.M. Hull, J.C. Clark, and M.A. O'Reilly. 1992. Transforming growth factor-β inhibits surfactant protein A expression in vitro. Biochim. Biophys. Acta. 1123:257-262.
49. Acarregui, M.J., J.M. Snyder, M.D. Mitchell, and C.R. Mendelson. 1990. Prostaglandins regulate surfactant protein A (SP-A) gene expression in human fetal lung in vitro. Endocrinology. 127:1105-1113.
50. Gwosdow, A.R., M.S. Kumar, and H.H. Bode. 1990. Interleukin-1 stimulation of the hypothalamic-pituitary-adrenal axis. Am. J. Physiol. 258:E65-E70.
51. Barna, I., Z. Acs, G. Bugovics, and J.I. Koenig. 1995. Effect of interleukin-1β on plasma ACTH, beta-endorphin, and corticosterone in infant and prepubertal rats. Pediatr. Res. 37:714-719.
52. Rivier, C. 1994. Stimulatory effect of interleukin-1β on the hypothalamic-pituitary-adrenal axis of the rat: influence of age, gender and circulating sex steroids. J. Endocrinol. 140:365-372.
53. Klein, J.M., and H.C. Nielsen. 1993. Androgen regulation of epidermal growth factor receptor binding activity during fetal rabbit lung development. J. Clin. Invest. 91:425-431.
54. Stoechle, M.Y. 1991. Post-translational regulation of groα, β, γ, and IL-8 mRNAs by IL-1β. Nucleic Acids Res. 19:917-920.
55. Saklatvala, J. 1995. Intracellular signaling mechanisms of IL-I and TNF: possible targets for therapy. Br. Med. Bull. 51:402-418.
56. Rust, K., L. Bingle, W. Mariencheck, A. Persson, and E.C. Croch. 1996. Characterization of the human surfactant protein D promoter: transcriptional regulation of SP-D gene expression by glucocorticoids. Am. J. Resp. Cell Mol. Biol. 14:121-130.